Eszter Nagy

This inventor holds 42 USPTO granted patents and 29 published patent applications, plus 3 CIPO patents and 10 EPO patents, primarily in Immunotherapy Research. Top assignees: Intercell Ag, Valneva Austria Gmbh, Arsanis Biosciences Gmbh. Active years: 2008-2026.

USPTO Granted Patents = 42 (Patent Applications = 29)

% Patents Active = 35.7

CIPO Patents = 3 (Patent Applications = 13)

EPO Patents = 10 (Patent Applications = 70)

Average Co-Inventor Count = 6.1

ph-index = 7

Forward Citations = 151(Granted Patents)

Location History:

Vienna, AU (2013)
Vienna, AT (2008 - 2022)
Wein, AT (2022)

Company Filing History:

Arsanis Biosciences Gmbh

X4 Pharmaceuticals (Austria) Gmbh

Janssen Pharmaceuticals, Inc.

patents

8. 1 out of 1

Eveliqure Biotechnologies Gmbh

patent

9. 1 out of 1,330

Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V.

patents

where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...

Areas of Expertise:

Immunotherapy

Specific Antibodies

Vaccine Composition

Antiviral Treatment

Pathogen Antigens

Galactan-Based O-Antigen

Live Attenuated Vaccine

Adjuvant Properties

MDR Immunogen

Streptococcus Antigens

Enterococcus Antigens

Isolation and Production

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12636356 - HIGH DOSE SHIGELLA VACCINE PREPARATION (2026-05-26),

2. 12274742 - MDRimmunogen (2025-04-14),

3. 12103962 - specific antibodies (2024-10-01),

4. 11529405 - MDRimmunogen (2022-12-20),

5. 11466074 - Antibodies targeting a galactan-based O-antigen of K. pneumoniae (2022-10-11),

6. 11433080 - Antiviral treatment (2022-09-06),

7. 11273163 - Antiviral treatment (2022-03-15),

8. 10940191 - MDRspecific antibody (2021-03-09),

9. 10759848 - O3 specific antibodies (2020-09-01),

10. 10206992 - [object Object] (2019-02-19),

11. 9914767 - [object Object] (2018-03-13),

12. 9849169 - [object Object] (2017-12-26),

13. 9730991 - Live attenuated Shigella vaccine (2017-08-15),

14. 8952135 - [object Object] (2015-02-10),

15. 8900564 - Vaccine composition comprising an antigen and a peptide having adjuvant properties (2014-12-02),

Title: Eszter Nagy: Innovator in Antibody Development

Introduction

Eszter Nagy is a prominent inventor based in Vienna, Austria, known for her significant contributions to the field of antibody development. With an impressive portfolio of 40 patents, she has made substantial advancements in biotechnology that impact medical diagnostics and treatment.

Latest Patents

Among her latest innovations, Eszter has developed specific antibodies targeting the O25b antigen, relevant to various strains. This invention focuses on an isolated antibody that includes an antibody heavy chain variable region (VH) with specific CDR sequences and may involve an antibody light chain variable region (VL). Additionally, she has contributed to the creation of a multi-drug resistant (MDR) immunogen, which involves an isolated antibody that binds to the O25b antigen of MDR strains. This patent outlines its medical and diagnostic applications, including methods for production and the necessary nucleotide sequences involved in creating the antibody.

Career Highlights

Eszter Nagy has collaborated with notable companies in the biotechnology sector, including Intercell AG and Valneva Austria GmbH. Her work in these organizations has fostered the development of cutting-edge therapies and diagnostics, solidifying her reputation as a leading innovator in the field.

Collaborations

Throughout her career, Eszter has worked alongside esteemed colleagues such as Andreas Meinke and Markus Hanner. These collaborations have enriched her research and broadened the impact of her inventions on the scientific community.

Conclusion

With her extensive experience and groundbreaking contributions, Eszter Nagy stands out as an influential inventor in the realm of antibody technology. Her continued dedication to innovation promises to lead to further advancements that will benefit medical science and patient care.